Review
Accepted on 05 Feb 2025
Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1521388
Type at least 3 characters
7,163 articles
Articles
Original Research
Accepted on 05 Feb 2025
The C/EBPβ antagonist peptide Lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1522699
- 125 views
Original Research
Accepted on 05 Feb 2025
Maplirpacept: A CD47 Decoy Receptor with Minimal Red Blood Cell Binding and Robust Anti-Tumor Efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1518787
- 110 views
Review
Accepted on 05 Feb 2025
The Potential Applications of Peptide-Loading Complex in Cancer Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1526137
Mini Review
Published on 05 Feb 2025
Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554256
- 899 views
Review
Published on 05 Feb 2025
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1518144
- 272 views
Original Research
Published on 05 Feb 2025
Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1512867
- 448 views
Original Research
Published on 05 Feb 2025
IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1535554
- 507 views
Case Report
Published on 05 Feb 2025
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1492296
- 260 views
Original Research
Published on 05 Feb 2025
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1477100
- 478 views
Original Research
Published on 05 Feb 2025
Polymorphisms in immunosuppression-related genes are associated with AML
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1530510
- 378 views
Review
Accepted on 04 Feb 2025
Neutrophils in Colorectal Cancer: Mechanisms, Prognostic Value, and Therapeutic Implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1538635
Original Research
Accepted on 04 Feb 2025
Prognostic Analysis and Identification of M7G Immune-Related Genes in Lung Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1515838
Original Research
Accepted on 04 Feb 2025
Multiparameter flow cytometric and transcriptional analyis of CD20 positive T-cells in bone marrow in patients of multiple myeloma and monoclonal gammopathy of undetermined significance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1464940
- 122 views
Original Research
Accepted on 04 Feb 2025
Metabolic Pathway Activation and Immune Microenvironment Features in Non-Small Cell Lung Cancer: Insights from Single-Cell Transcriptomics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546764
Case Report
Published on 04 Feb 2025
Case report: Multi-organ injuries induced by tislelizumab
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1508293
- 388 views